Generic Pharmaceuticals Global Market Opportunities And Strategies To 2030: COVID-19 Impact And Recovery provides the strategists; marketers and senior management with the critical information they need to assess the global generic pharmaceuticals market as it emerges from the COVID 19 shut down.
Description: Where is the largest and fastest growing market for the generic pharmaceuticals? How does the market relate to the overall economy; demography and other similar markets? What forces will shape the market going forward? The generic pharmaceuticals market global report answers all these questions and many more. The report covers market characteristics; size and growth; segmentation; regional and country breakdowns; competitive landscape; market shares; trends and strategies for this market.It traces the market’s historic and forecast market growth by geography.
It places the market within the context of the wider generic pharmaceuticals market; and compares it with other markets.
The report covers the following chapters Executive Summary – The executive summary section of the report gives a brief overview and summary of the report Report Structure – This section gives the structure of the report and the information covered in the various sections. Introduction – The introduction section of the report gives brief introduction about segmentation by geography, segmentation by therapy, segmentation by distribution channel, and segmentation by type, and by drug delivery. Market Characteristics – The market characteristics section of the report defines and explains the electric commercial vehicles market. This chapter also defines and describes goods and related services covered in the report. Trends And Strategies – This chapter describes the major trends shaping the global generic pharmaceutical market. This section highlights likely future developments in the market and suggests approaches companies can take to exploit these opportunities. COVID-19 Impact – This chapter describes the impact that the COVID-19 pandemic had across various industries and companies in the generic pharmaceutical industry. Global Market Size And Growth – This section contains the global historic (2015-2020) and forecast (2025F, 2030F) market values, and drivers and restraints that support and restrain the growth of the market in the historic and forecast periods. Regional Analysis – This section contains the historic (2015-2020), forecast (2020-2025F, 2030F) market value and growth and market share comparison by region. Segmentation – This section contains the market values (2015-2020, 2025F, 2030F) and analysis for different segments in the market. Regional Market Size And Growth – This section contains the region’s market size (2020), historic and forecast (2015-2025, 2030F) market values, and growth and market share comparison of major countries within the region. This report includes information on all the regions (Asia Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa). Competitive Landscape – This section covers details on the competitive landscape of the global generic pharmaceutical market, estimated market shares and company profiles of the leading players. Key Mergers And Acquisitions – This chapter gives the information on recent mergers and acquisitions in the market covered in the report. This section gives key financial details of mergers and acquisitions which have shaped the market in recent years. Market Opportunities And Strategies– This section includes market opportunities and strategies based on findings of the research.This section also gives information on growth opportunities across countries, segments and strategies to be followed in those markets.
It gives an understanding of where there is significant business to be gained by competitors in the next five years. Recommendations – This section includes conclusions and recommendations based on findings of the research. This section also gives recommendations for generic pharmaceuticals in terms of product offerings, geographic expansion, marketing strategies and target groups. Appendix – This section includes details on the NAICS codes covered, abbreviations and currencies codes used in this report.
Scope Markets Covered: 1) By Therapy: CNS; Cardiovascular; Dermatology; Genitourinary/Harmonal; Respiratory; Rheumatology; Diabetes; Oncology; Biosimilars; Others 2) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Online Pharmacies 3) By Type: Biosimilars; Generics 4) By Drug Delivery: Oral; Injectables; Dermal/Topical; Inhalers
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets; GDP proportions; expenditure per capita; generic pharmaceutical indicators comparison.
Data segmentations: country and regional historic and forecast data; market share of competitors; market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Reasons to Purchase • Gain a truly global perspective with the most comprehensive report available on this market covering 12 geographies. • Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates. • Create regional and country strategies on the basis of local data and analysis. • Identify growth segments for investment. • Outperform competitors using forecast data and the drivers and trends shaping the market. • Understand customers based on the latest market research findings. • Benchmark performance against key competitors. • Utilize the relationships between key data sets for superior strategizing. • Suitable for supporting your internal and external presentations with reliable high quality data and analysis • Report will be updated with the latest data and delivered to you within 3-5 working days of order.
Our reports have been used by over 10K customers, including:
The generic drugs market was valued at USD 364,925.27 million in 2021, and it is expected to reach USD 468,787.86 million by 2027, registering a CAGR of 4.27% during the forecast period of 2022-2027. During the early pandemic, COVID-19 has severly impacted the generic drugs market due to the lockdown restrictions and supply chain disruption....
In recent times there has been a growing focus on the generic drugs industry worldwide. The patent expiry of leading drugs in recent years and also the upcoming patent expiries has put a focus on the global generics industry. Over the years, the global generic drugs industry has grown strongly owing partly to the fact that the period for patent...
The Future of Generic Drugs and Strategies for Commercial Success Summary Generic drugs are identical or bioequivalent to branded drugs in dosage form, safety, strength, route of administration, quality, performance characteristics and intended use. Although generic drugs are chemically identical to their branded...
A generic drug is a copy that is the same as a brand-name drug in dosage, safety, strength, how it is taken, quality, performance and intended use. Generic drugs are less expensive because generic manufacturers don't have the investment costs of the developer of a new drug. New drugs are developed under patent protection. The...
You can change your Cookie Settings at any time but parts of our site will not function correctly without them.